Enphase_Logo_Standard_orange_gray_RGB copy.jpg
Enphase Energy Announces Conference Call to Review First Quarter 2024 Financial Results Tuesday, April 23, 2024 at 4:30 p.m. Eastern Time
April 09, 2024 08:00 ET | Enphase Energy, Inc.
FREMONT, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery...
parpacificLogo.png
Par Pacific Announces First Quarter 2024 Earnings Release and Conference Call Schedule
April 09, 2024 08:00 ET | Par Pacific Holdings, Inc.
HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its first quarter 2024 results after the New York Stock...
Aligos.png
Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024
April 09, 2024 08:00 ET | Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel...
BFRG logo.png
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
April 09, 2024 08:00 ET | BullFrog AI Holdings, Inc.
GAITHERSBURG, Md., April 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...
RTI.jpg
RTI and GE HealthCare Take the Stage at DeviceTalks Boston 2024
April 09, 2024 08:00 ET | Real-Time Innovations (RTI)
RTI and GE HealthCare take the stage at DeviceTalks Boston 2024.
briacell-logo-square-a.jpg
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
April 09, 2024 08:00 ET | BriaCell Therapeutics Corp.
PFS of 4.2 months in Phase 2 ADC resistant patients receiving Bria-IMT™ pivotal Phase 3 formulation is twice that of controls in similar studies PFS results reinforced by larger number of prior...
Sysco_Logo-At_the_heart-Color v2.png
Sysco to Announce Third Quarter Fiscal Year 2024 Financial Results on April 30
April 09, 2024 08:00 ET | Sysco Corporation
HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its third quarter fiscal year 2024 financial results at 10 a.m. EDT on...
EFTR.png
eFFECTOR Therapeutics to Participate in Upcoming Investor Conference
April 09, 2024 08:00 ET | eFFECTOR Therapeutics, Inc.
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator...
black letters white rectangle.jpg
LVT Unveils Immix Integration and New Cameras to Bolster Intelligent Physical Security Ecosystem
April 09, 2024 08:00 ET | LiveView Technologies
LVT launches integration with Immix and adds two new cameras
Profound_Logo_CMYK copy.jpg
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 09, 2024 07:45 ET | Profound Medical Corp.
TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...